News

Molecules released into the blood following mild traumatic brain injury may be indicators of neuronal damage associated with complications, according to new research.

A team from Duke University has developed a synthetic molecule that selectively dampens the physiological rewards of cocaine in mice. This molecule could represent a new class of drugs that may be more specific that currently available medications, with fewer adverse effects.

A study has discovered two potential candidates to treat Alzheimer’s disease. The two marine molecules, meridianine and lignarenone B, can alter the activity of GSK3B activity, a protein linked to several neurodegenerative diseases.

A potential blood-based biomarker for Alzheimer's and other neurodegenerative diseases seems even more promising thanks to new research from a Massachusetts General Hospital-led study.

An international research team has for the first time obtained the structure of the light-sensitive sodium-pumping KR2 protein in its active state.

The earliest brain changes due to Huntington’s disease can be detected 24 years before clinical symptoms show, according to new research.

Auditory hallucinations – a symptom of schizophrenia – have been linked to a hyper-connection between the substructures of the thalamus and the cortex regions associated with hearing.

Giving beneficial bacteria to stressed mothers during the equivalent of the third trimester of pregnancy prevents an autism-like disorder in their offspring, according to a new animal study by University of Colorado Boulder researchers.

New research has shed light on the molecular motors underlying our ability to hear and the role that they can play in genetic hearing loss.

A novel method for electric stimulation of the vagus nerve could be used to treat chronic pain, according to a new study.